← Frontiers in Hematology

Papers in Frontiers in Hematology

Page 4 · newest first

151. Global burden and unmet needs in the treatment of transfusion-dependent β-thalassemiaFrontiers in Hematology · 2023
152. Peripherally inserted central catheter insertion and management in Hodgkin and non-Hodgkin lymphomas: a 13-year monocentric experienceFrontiers in Hematology · 2023
153. Case Report: A rare case of CD20-positive T-cell large granular lymphocyte leukemia with renal cell carcinoma: a challenging diagnosisFrontiers in Hematology · 2023
154. Case Report: Thrombopoietin receptor agonists in resistant thrombocytopenia in pregnancy: a case series and review of literatureFrontiers in Hematology · 2023
155. Post CAR T-cell therapy outcomes and management in HSCT-naive patients: a single-center experienceFrontiers in Hematology · 2023
156. Recent progress in analyses of GATA1 in hematopoietic disorders: a mini-reviewFrontiers in Hematology · 2023
157. Impact of haemoglobinopathies on asymptomatic Plasmodium falciparum infection and naturally acquired immunity among children in Northern GhanaFrontiers in Hematology · 2023
158. Development of the sickle Pan-African research consortium registry in Tanzania: opportunity to harness data science for sickle cell diseaseFrontiers in Hematology · 2023
159. Predicting outcomes of hematological malignancy patients admitted to critical careFrontiers in Hematology · 2023
160. Case report: Sustained complete remission with ivosidenib in a patient with relapsed, IDH1-mutated acute leukemiaFrontiers in Hematology · 2023
161. Identification factors to adjust early combination regimens in adult primary immune thrombocytopenia: An 8-year data analysisFrontiers in Hematology · 2023
162. Red blood cells from patients with sitosterolemia exhibit impaired membrane lipid composition and distribution and decreased deformabilityFrontiers in Hematology · 2023
163. Highly-sensitive chimerism analysis in blood after allogeneic hematopoietic cell transplantation in childhood leukemia: Results from the Nordic Microchimerism StudyFrontiers in Hematology · 2023
164. Benefits and limitations of humanized mouse models for human red blood cell-related disease researchFrontiers in Hematology · 2023
165. Innovative and Needs-led research on β-thalassemia treatment methodsFrontiers in Hematology · 2023
166. Case Report: A unique case of secondary hemophagocytic lymphohistiocytosis from ehrlichiosis infectionFrontiers in Hematology · 2022
167. Impact of insurance status and distance from residence to treatment center on the outcomes of patients diagnosed with acute myeloid leukemiaFrontiers in Hematology · 2022
168. Immunophenotypic transformation in relapsed/refractory mantle cell lymphoma treated with human anti-CD5 chimeric antigen receptor T cells: A Case ReportFrontiers in Hematology · 2022
169. Recombinant factor VIII Fc fusion protein engages monocytes via Fc and FVIII domains to reduce monocyte differentiation into osteoclastsFrontiers in Hematology · 2022
170. Ropeginterferon-alfa2b resolves angina pectoris and reduces JAK2V617F in a patient with clonal hematopoiesis of indeterminate potential: A case reportFrontiers in Hematology · 2022
171. Case report: Unexpected parvovirus B19 infection in a myeloma patient treated with daratumumabFrontiers in Hematology · 2022
172. Ex vivo culture of malignant primary B cellsFrontiers in Hematology · 2022
173. Case Report: Renal relapse after heart transplantation, induction, and autologous stem cell transplantation in a patient with AL amyloidosis with exclusive cardiac involvementFrontiers in Hematology · 2022
174. Case Report: Unique patterns of lymphocyte recovery post-hematopoietic stem cell transplant associated with hyperbaric oxygen therapy: A case seriesFrontiers in Hematology · 2022
175. Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresisFrontiers in Hematology · 2022